Rocío Toro Cebada-rekin lankidetzan egindako argitalpenak (13)

2023

  1. Prevalence of transthyretin cardiac amyloidosis in elderly patients diagnosed with heart failure

    Revista Espanola de Geriatria y Gerontologia, Vol. 58, Núm. 1, pp. 8-14

  2. Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis

    Journal of Clinical Medicine, Vol. 12, Núm. 8

2022

  1. The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  2. miR-16-5p Suppression Protects Human Cardiomyocytes against Endoplasmic Reticulum and Oxidative Stress-Induced Injury

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

2021

  1. Asymptomatic aortic stenosis in a geriatric population. The role of frailty and comorbidity in mortality

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 167-174

  2. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1711-1725

  3. Elderly population with COVID-19 and the accuracy of clinical scales and d-dimer for pulmonary embolism: The OCTA-COVID study

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  4. Ischemic dilated cardiomyopathy pathophysiology through microRNA-16-5p

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 740-749

  5. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

  6. Predictive factors of pulmonary embolism in older patients with sars-cov-2: The octa-covid-19 study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2020

  1. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy

    Translational Research, Vol. 218, pp. 1-15

2019

  1. Aortic stenosis prognosis in older patients: frailty is a strong marker of early congestive heart failure admissions: Influence of frailty in aortic stenosis

    European Geriatric Medicine, Vol. 10, Núm. 3, pp. 483-491

2017

  1. Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkers

    International Journal of Cardiology, Vol. 228, pp. 870-880